Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Topham

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Cancer Detection and Prevention|January 1, 1992
Sister chromatid exchange (SCE) frequency in lymphocytes of patients with colorectal carcinoma treated with razoxaneC M Price, D Hagger, M Evans, et al.
British Journal of Cancer|August 20, 2009
Preoperative downstaging chemoradiation with concurrent irinotecan and capecitabine in MRI-defined locally advanced rectal cancer: a phase I trial (NWCOG-2)S W Gollins, S Myint, S Susnerwala, et al.
Lancet (London, England)|February 14, 2003
Comparison of intermittent and continuous palliative chemotherapy for advanced colorectal cancer: a multicentre randomised trialT S Maughan, R D James, D J Kerr, et al.
British Journal of Cancer|August 1, 1976
Clinical trial of combination chemotherapy and specific active immunotherapy in disseminated melanomaE S Newlands, C J Oon, J T Roberts, et al.
Mutation Research|May 1, 1983
An evaluation of human sperm as indicators of chemically induced alterations of spermatogenic function. A report of the U.S. Environmental Protection Agency Gene-Tox ProgramA J Wyrobek, L A Gordon, J G Burkhart, et al.
British Journal of Cancer|September 15, 2004
Elderly patients with fluoropyrimidine and thymidylate synthase inhibitor-resistant advanced colorectal cancer derive similar benefit without excessive toxicity when treated with irinotecan monotherapyI Chau, A R Norman, D Cunningham, et al.
Mutation Research|May 1, 1983
An evaluation of the mouse sperm morphology test and other sperm tests in nonhuman mammals. A report of the U.S. Environmental Protection Agency Gene-Tox ProgramA J Wyrobek, L A Gordon, J G Burkhart, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Cancer Detection and Prevention|January 1, 1992
Sister chromatid exchange (SCE) frequency in lymphocytes of patients with colorectal carcinoma treated with razoxaneC M Price, D Hagger, M Evans, et al.
British Journal of Cancer|August 20, 2009
Preoperative downstaging chemoradiation with concurrent irinotecan and capecitabine in MRI-defined locally advanced rectal cancer: a phase I trial (NWCOG-2)S W Gollins, S Myint, S Susnerwala, et al.
Lancet (London, England)|February 14, 2003
Comparison of intermittent and continuous palliative chemotherapy for advanced colorectal cancer: a multicentre randomised trialT S Maughan, R D James, D J Kerr, et al.
British Journal of Cancer|August 1, 1976
Clinical trial of combination chemotherapy and specific active immunotherapy in disseminated melanomaE S Newlands, C J Oon, J T Roberts, et al.
Mutation Research|May 1, 1983
An evaluation of human sperm as indicators of chemically induced alterations of spermatogenic function. A report of the U.S. Environmental Protection Agency Gene-Tox ProgramA J Wyrobek, L A Gordon, J G Burkhart, et al.
British Journal of Cancer|September 15, 2004
Elderly patients with fluoropyrimidine and thymidylate synthase inhibitor-resistant advanced colorectal cancer derive similar benefit without excessive toxicity when treated with irinotecan monotherapyI Chau, A R Norman, D Cunningham, et al.
Mutation Research|May 1, 1983
An evaluation of the mouse sperm morphology test and other sperm tests in nonhuman mammals. A report of the U.S. Environmental Protection Agency Gene-Tox ProgramA J Wyrobek, L A Gordon, J G Burkhart, et al.
Pageof 4